| Negative impact of a 1-month period of night shifts on mental and physical health among Swiss internal medicine residents | Swiss medical weekly |  | | 2026 | 6 | 12 |
|
| The ICARUS project : study protocol for a randomised controlled trial Investigating aCute heArt failuRe decongestion guided by lung UltraSonography | Trials | | | 2026 | 26 | 192 |
|
| Association between point‐of‐care ultrasonography use and requests for formal imaging studies in hospital‐based internal medicine : A retrospective cohort study | Journal of hospital medicine |  | | 2026 | 13 | 0 |
|
| Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study | PloS one | | | 2026 | 44 | 180 |
|
| Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants | Frontiers in pharmacology | | | 2026 | 21 | 38 |
|
| MicroRNA-223-3p is a determinant of platelet procoagulant activity | Blood advances | | | 2026 | 33 | 250 |
|
| The zebrafish model tackles anti-P2Y12 variability in humans : a translational approach | Blood advances | | | 2026 | 19 | 6 |
|
| Pharmacologic Thromboprophylaxis in Medical Inpatients | JAMA network open | | | 2026 | 13 | 8 |
|
| A historical review of the biological, semantic and clinical aspects of aspirin resistance | Journal of thrombosis and haemostasis | | | 2026 | 11 | 0 |
|
| The widening gap between point-of-care ultrasonography course participation and supervision resources | European journal of internal medicine | | | 2026 | 14 | 0 |
|
| Impact of care reorganisation during COVID-19 waves on non-COVID-19 inpatients in a Swiss hospital : a retrospective cohort study | Swiss medical weekly | | | 2026 | 23 | 44 |
|
| Impact of a booster intervention of the ‘More Time at Patients’ Side’ programme on patients and healthcare professionals in a Swiss hospital : protocol for a cluster randomised controlled trial | BMJ open | | | 2026 | 19 | 65 |
|
| Cytochrome P450 phenotyping using the Geneva cocktail improves metabolic capacity prediction in a hospitalized patient population | British journal of clinical pharmacology | | | 2025 | 63 | 0 |
|
| Inflammatory predictors of Post-COVID fatigue | Brain, behavior, & immunity. Health | | | 2025 | 23 | 57 |
|
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics | | | 2025 | 82 | 238 |
|
| Impact de la réorganisation des soins pendant les vagues de COVID-19 sur les patients hospitalisés pour un autre diagnostic que le COVID : étude de cohorte rétrospective monocentrique | 90e Congrès Français de Médecine Interne | | | 2025 | 64 | 0 |
|
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology | | | 2025 | 97 | 1 |
|
| Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection | Scientific reports | | | 2024 | 77 | 208 |
|
| Monitoring low-value care in medical patients from Swiss university hospitals using a Findable, Accessible, Interoperable, Reusable (FAIR) national data stream and patient and public involvement : LUCID study protocol | BMJ open | | | 2024 | 75 | 195 |
|
| Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohort | Journal of global health | | | 2024 | 140 | 197 |
|
| Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study) | BMJ open | | | 2024 | 119 | 293 |
|
| Internistes et généralistes ! | Revue médicale suisse | | | 2024 | 7 | 7 |
|
| Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort | Archives of clinical neuropsychology | | | 2023 | 508 | 476 |
|
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infection | Human brain mapping | | | 2023 | 293 | 244 |
|
| Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection | Psychoneuroendocrinology | | | 2023 | 219 | 199 |
|
| Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort study | Swiss medical weekly | | | 2023 | 79 | 197 |
|
| Markers of limbic system damage following SARS-CoV-2 infection | Brain communications | | | 2023 | 287 | 126 |
|
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | | 2023 | 156 | 600 |
|
| The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll | Scientific reports | | | 2023 | 165 | 46 |
|
| Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital | Scientific reports | | | 2023 | 216 | 165 |
|
| Enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adult medical patients | NEJM evidence | | | 2023 | 116 | 0 |
|
| Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status | Clinical infectious diseases | | | 2023 | 181 | 344 |
|
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | | 2023 | 145 | 534 |
|
| PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations | BMJ | | | 2022 | 37 | 0 |
|
| Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia | BMC infectious diseases | | | 2022 | 94 | 209 |
|
| A bilateral aseptic pyogenic ventriculitis following a course of pembrolizumab, an anti-PD-1 immune checkpoint inhibitor treatment for metastatic small cell lung cancer | Thérapie | | | 2022 | 66 | 0 |
|
| One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals | Journal of internal medicine | | | 2022 | 284 | 143 |
|
| Comparison of prognostic scores for inpatients with COVID-19: a retrospective monocentric cohort study | BMJ open respiratory research | | | 2022 | 310 | 193 |
|
| Avancées récentes en médecine interne | Revue médicale suisse | | | 2022 | 217 | 166 |
|
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | | | 2022 | 166 | 208 |
|
| Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative study | Internal and emergency medicine | | | 2022 | 305 | 241 |
|
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | | 2022 | 234 | 456 |
|
| Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial | Research and practice in thrombosis and haemostasis | | | 2022 | 259 | 327 |
|
| Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis | Atherosclerosis | | | 2022 | 160 | 534 |
|
| Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation | Clinical pharmacology and therapeutics | | | 2022 | 175 | 355 |
|
| Development and assessment of PharmaCheck: an electronic screening tool for the prevention of twenty major adverse drug events | BMC medical informatics and decision making | | | 2022 | 300 | 408 |
|
| Confidence and use of physical examination and point-of-care ultrasonography for detection of abdominal or pleural free fluid. A cross-sectional survey | Internal and emergency medicine | | | 2022 | 235 | 259 |
|
| The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital | Preventive medicine reports | | | 2022 | 267 | 201 |
|
| Risk stratification for hospital-acquired venous thromboembolism in medical patients (RISE): Protocol for a prospective cohort study | PloS one | | | 2022 | 481 | 559 |
|
| Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P-Glycoprotein Activities | Clinical pharmacology and therapeutics | | | 2022 | 191 | 405 |
|
| Kinetics of inflammatory biomarkers to predict one-year mortality in older patients hospitalized for pneumonia: a multivariable analysis | International journal of infectious diseases | | | 2022 | 225 | 375 |
|
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization | Scientific reports | | | 2022 | 234 | 134 |
|
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | | 2021 | 221 | 290 |
|
| Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure | Journal of clinical medicine | | | 2021 | 241 | 148 |
|
| miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa | Thrombosis and haemostasis | | | 2021 | 112 | 121 |
|
| Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy | Annual Review of Pharmacology and Toxicology | | | 2021 | 467 | 1 |
|
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | | 2021 | 189 | 0 |
|
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | | | 2021 | 297 | 5 |
|
| 2020 en revue par les internistes hospitaliers | Revue médicale suisse | | | 2021 | 249 | 383 |
|
| Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19 | European journal of hospital pharmacy | | | 2021 | 233 | 0 |
|
| An Ex Vivo and In Silico Study Providing Insights into the Interplay of Circulating miRNAs Level, Platelet Reactivity and Thrombin Generation: Looking beyond Traditional Pharmacogenetics | Journal of Personalized Medicine | | | 2021 | 261 | 325 |
|
| Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia | Journal of clinical medicine | | | 2021 | 280 | 237 |
|
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | | | 2021 | 358 | 237 |
|
| Role of Intermediate Care Unit Admission and Noninvasive Respiratory Support during the COVID-19 Pandemic: A Retrospective Cohort Study | Respiration | | | 2021 | 237 | 339 |
|
| Accuracy of C-reactive protein, procalcitonin, serum amyloid A and neopterin for low-dose CT-scan confirmed pneumonia in elderly patients: A prospective cohort study | PLOS ONE | | | 2020 | 376 | 357 |
|
| Platelet function test use for patients with coronary artery disease in the early 2020s | Journal of clinical medicine | | | 2020 | 209 | 206 |
|
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | | | 2020 | 519 | 560 |
|
| Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium | Clinical Pharmacology and Therapeutics | | | 2020 | 213 | 127 |
|
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | | | 2020 | 469 | 506 |
|
| MicroRNA-126 is a regulator of platelet-supported thrombin generation | Platelets | | | 2020 | 322 | 425 |
|
| The well-being of Swiss general internal medicine residents | Swiss Medical Weekly | | | 2020 | 371 | 288 |
|
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | | | 2020 | 389 | 253 |
|
| Point of care ultrasonography from the emergency department to the internal medicine ward: current trends and perspectives | Internal and Emergency Medicine | | | 2020 | 328 | 2,325 |
|
| Guillain-Barré syndrome as a complication of SARS-CoV-2 infection | Brain, behavior, and immunity | | | 2020 | 276 | 206 |
|
| Functional Independence Measure score is associated with mortality in critically ill elderly patients admitted to an intermediate care unit | BMC Geriatrics | | | 2020 | 242 | 320 |
|
| Feasibility and safety of high-intensity interval training for the rehabilitation of geriatric inpatients (HIITERGY) a pilot randomized study | BMC Geriatrics | | | 2020 | 300 | 409 |
|
| Vegetarian, pescatarian and flexitarian diets: sociodemographic determinants and association with cardiovascular risk factors in a Swiss urban population | The British journal of nutrition | | | 2020 | 233 | 330 |
|
| Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients | Journal of Thrombosis and Haemostasis | | | 2020 | 302 | 1 |
|
| Methods to investigate miRNA function: focus on platelet reactivity | Thrombosis and Haemostasis | | | 2020 | 258 | 221 |
|
| A high glucose level is associated with decreased aspirin-mediated acetylation of platelet cyclooxygenase (COX)-1 at serine 529: A pilot study | Journal of Proteomics | | | 2019 | 538 | 660 |
|
| Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells | Thrombosis and Haemostasis | | | 2019 | 524 | 541 |
|
| Associations between early handoffs, length of stay and complications in internal medicine wards: A retrospective study | European journal of internal medicine | | | 2019 | 196 | 1 |
|
| Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants | Clinical Pharmacokinetics | | | 2019 | 514 | 2 |
|
| Médecine interne hospitalière en revue | Revue médicale suisse | | | 2019 | 275 | 180 |
|
| Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis | PLOS ONE | | | 2019 | 291 | 340 |
|
| Platelet Function Testing or Genotyping: Which Should We Trust? | JACC: Cardiovascular Interventions | | | 2019 | 230 | 0 |
|
| Accuracy of comprehensive PCR analysis of nasopharyngeal and oropharyngeal swabs for CT-scan-confirmed pneumonia in elderly patients: a prospective cohort study | Clinical Microbiology and Infection | | | 2019 | 457 | 261 |
|
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | | | 2018 | 749 | 961 |
|
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | | | 2018 | 533 | 1,204 |
|
| Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC) | American Heart Journal | | | 2018 | 502 | 301 |
|
| Large bowel obstruction: a case of uncommon aetiology of a frequent condition | Age and Ageing | | | 2018 | 282 | 0 |
|
| Low-dose computed tomography for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study | European Respiratory Journal | | | 2018 | 556 | 262 |
|
| Platelet reactivity in stable cardiovascular patients with chronic kidney disease | Platelets | | | 2018 | 536 | 0 |
|
| Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective Study | Journal of Bone and Mineral Research | | | 2018 | 550 | 3 |
|
| Shotgun proteomics data on the impact of hyperglycaemia on platelet protein acetylation by aspirin | Data in Brief | | | 2018 | 502 | 223 |
|
| Diagnosis of systemic lupus erythematosus by presence of Hargraves cells in eosinophilic pleural effusion | Medicine (Baltimore) | | | 2018 | 251 | 186 |
|
| Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients | Cell communication & adhesion | | | 2017 | 586 | 2 |
|
| Acute Appendicitis in Elderly Adults: A Difficult Diagnosis | Journal of the American Geriatrics Society | | | 2016 | 667 | 0 |
|
| Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data | Thrombosis and haemostasis | | | 2016 | 591 | 341 |
|
| Genetics of clopidogrel poor-response | Antiplatelet Therapy in Cardiovascular Disease | | | 2016 | 528 | 0 |
|
| New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach | Human genetics | | | 2016 | 846 | 397 |
|
| Sepsis chez le sujet âgé : quelles spécificités ? | Revue médicale suisse | | | 2016 | 725 | 769 |
|
| PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients | Stroke | | | 2016 | 571 | 0 |
|
| Aspirin response: Differences in serum thromboxane B2 levels between clinical studies | Platelets | | | 2016 | 728 | 1 |
|
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | | | 2016 | 682 | 1,095 |
|
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | | | 2016 | 636 | 0 |
|
| Simple comme un SMS ! | La Revue de médecine interne | | | 2016 | 525 | 146 |
|
| TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke | Stroke | | | 2016 | 539 | 0 |
|
| An unusual cause of bilateral lower extremity edema in an older woman | Journal of the American Geriatrics Society | | | 2015 | 581 | 2 |
|
| Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies? | Expert opinion on pharmacotherapy | | | 2015 | 693 | 2 |
|
| Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy | Arthritis & rheumatology | | | 2015 | 614 | 0 |
|
| Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study | Platelets | | | 2015 | 597 | 0 |
|
| Mon patient est trop âgé pour une statine : mythes et réalités | Revue médicale suisse | | | 2015 | 491 | 0 |
|
| Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis | European journal of vascular and endovascular surgery | | | 2015 | 601 | 334 |
|
| Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing? | Platelets | | | 2015 | 695 | 3 |
|
| A Case of Tuberculous Granulomatous Panniculitis without Vasculitis | Case reports in dermatology | | | 2015 | 646 | 377 |
|
| Pneumonie chez le sujet âgé : y a-t-il des spécificités ? | Revue médicale suisse | | | 2014 | 632 | 2 |
|
| Hémostase. Aspirine: une ou deux fois par jour? | Revue médicale suisse | | | 2014 | 596 | 0 |
|
| How to manage prasugrel and ticagrelor in daily practice | European journal of internal medicine | | | 2014 | 518 | 912 |
|
| Antiplatelet Therapy: Targeting the TxA2 Pathway | Journal of cardiovascular translational research | | | 2014 | 665 | 2 |
|
| Role of paraoxonase-1 in CYP2C19 loss-of-function carriers | Thrombosis research | | | 2014 | 686 | 0 |
|
| Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granules | Journal of proteomics | | | 2014 | 806 | 3 |
|
| Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | | | 2013 | 605 | 0 |
|
| Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ? | Revue médicale suisse | | | 2013 | 602 | 0 |
|
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding | Journal of the American College of Cardiology | | | 2013 | 547 | 2,029 |
|
| Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigm | Translational proteomics | | | 2013 | 672 | 639 |
|
| Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study | Circulation | | | 2012 | 749 | 128 |
|
| Intramural hematoma of the esophagus | Case reports in gastroenterology | | | 2012 | 554 | 0 |
|
| Application pratique et intérêt des recommandations de prise en charge des syncopes : évaluation de pratiques professionnelles | Annales de cardiologie et d'angéiologie | | | 2012 | 582 | 0 |
|
| Prevalence of poor biological response to clopidogrel: a systematic review | Thrombosis and haemostasis | | | 2012 | 566 | 0 |
|
| Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management | Cardiovascular therapeutics | | | 2012 | 645 | 0 |
|
| Nutrition entérale : sonde nasogastrique ou gastrostomie percutanée endoscopique? | Revue médicale suisse | | | 2012 | 657 | 2 |
|
| Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | | 2012 | 636 | 0 |
|
| Severe mitral valve regurgitation in polymyositis | Journal of clinical rheumatology | | | 2012 | 576 | 0 |
|
| The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro | British journal of pharmacology | | | 2012 | 604 | 0 |
|
| Thrombose coronaire distale compliquant une leucémie aiguë lymphoblastique traitée par asparaginase | Annales de cardiologie et d'angéiologie | | | 2012 | 717 | 624 |
|
| Platelet proteomics | Mass spectrometry reviews | | | 2012 | 558 | 2 |
|
| Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study | Journal of thrombosis and haemostasis | | | 2011 | 650 | 0 |
|
| Une histoire pas très originale dans un contexte pas très confortable...Hemoptysis in a 55-year-old man | La Revue de médecine interne | | | 2011 | 645 | 0 |
|
| Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients | Thrombosis and haemostasis | | | 2011 | 664 | 0 |
|
| Anémie ferriprive, inflammatoire ou mixte: comment orienter le diagnostic? | Revue médicale suisse | | | 2011 | 1,330 | 5 |
|
| Médecine interne hospitalière : l'année 2010 en revue (1) | Revue médicale suisse | | | 2011 | 983 | 0 |
|
| Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | | 2010 | 596 | 0 |
|
| Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique | Revue médicale suisse | | | 2010 | 619 | 0 |
|
| Médecine interne hospitalière : l'année 2009 en revue (2) | Revue médicale suisse | | | 2010 | 608 | 1 |
|
| Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? | Revue médicale suisse | | | 2010 | 532 | 0 |
|
| Antiagregants plaquettaires : lequel, quand et pour qui ? | La Revue de médecine interne | | | 2010 | 522 | 0 |
|
| Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study | Journal of thrombosis and haemostasis | | | 2010 | 624 | 0 |
|
| Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance | Current vascular pharmacology | | | 2009 | 544 | 0 |
|
| Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique | La Revue de médecine interne | | | 2009 | 574 | 0 |
|
| Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? | Journal of thrombosis and haemostasis | | | 2009 | 536 | 0 |
|
| Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis | Journal of thrombosis and haemostasis | | | 2008 | 674 | 0 |
|
| Laboratory-defined aspirin resistance and recurrent cardiovascular events | Archives of internal medicine | | | 2008 | 593 | 0 |
|
| Aspirin "resistance" and risk of cardiovascular morbidity | BMJ. British medical journal | | | 2008 | 549 | 1 |
|
| Aspirin response variability assessed with the PFA-100 device | Thrombosis and haemostasis | | | 2008 | 620 | 0 |
|
| Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects | Circulation | | | 2003 | 349 | 385 |
|
